OncologyPaclitaxel
October 14, 2017

Saladax is Awarded “Best Poster Presentation” for Study on Individualized Dosing of Paclitaxel

Saladax Biomedical, Inc., recently presented a study on the value of adjusting paclitaxel doses.  The…
Read More
OncologyPaclitaxel
October 19, 2016

Study Shows That Therapeutic Drug Monitoring Can Reduce Paclitaxel-Associated Neuropathy

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic tests, today announced…
Read More
OncologyPaclitaxel
June 9, 2015

Saladax Biomedical, Inc. Announces Presentation of CEPAC-TDM Study of Paclitaxel in Non-Small Cell Lung Cancer at 2015 ASCO Meeting

Large Study Confirms the Benefit to Patients of Advanced Dosing Method for Saladax Biomedical, Inc.…
Read More
5-FU
June 8, 2015

Saladax Biomedical, Inc. Announces the Presentation of the CESAR Study Results for Pharmacokinetically-Guided Dosing of 5-Fluorouracil in Colorectal Cancer at 2015 ASCO Meeting

Advantages of a Practical Approach to Personalized Dosing of 5-FU Demonstrated Saladax Biomedical, Inc. recently…
Read More
ImatinibOncology
December 1, 2014

Saladax Biomedical Announces U.S. Launch of MyImatinib™ Chemotherapy Exposure Optimization Test

Commercial Launch of MyImatinib™ Test Expands MyCare™ portfolio of Chemotherapy Exposure Optimization tests available from…
Read More